open access

Vol 5, No 1 (2004): Practical Diabetology
Original articles (submitted)
Published online: 2004-02-02
Get Citation

A cost-effectiveness analysis of treatment of diabetic complications in 2002

Paweł Kawalec, Andrzej Pilc
Diabetologia Praktyczna 2004;5(1):9-14.

open access

Vol 5, No 1 (2004): Practical Diabetology
Original articles (submitted)
Published online: 2004-02-02

Abstract

INTRODUCTION. For the time being no complex elaboration on the topic have been carried out in Poland thus results of the study could make it easier to emphasize the role of proper prophylaxis on reduction of incidence of diabetic complications and costs of diabetes in Poland in perspective of public payer; it could occur basic for new diabetes policy in Poland.
MATERIAL AND METHODS. The aim of the study was to assess costs for treatment of diabetes complications as well as an elaboration of a group of complications: microangiopathy or macroangiopathy are more cost-generating for public payer in 2002. Relevant data was obtained from two sources: identification of patients with diagnosed diabetes; identification of all procedures for treatment of the patients.
RESULTS. Costs for reimbursement for treatment of diabetes complications in Poland in 2002 were assessed to be 435 million PLN in 2002.
CONCLUSIONS. Proper prophylaxis and reduction of incidence of diabetic complications would mean lower costs for treatment of diabetic complications. Pharmacoeconomic elaboration should occur a new impulse for new diabetic policy which mean elaboration and implementation for more efficient health programmes and better control for glucose level in diabetic patients in Poland.

Abstract

INTRODUCTION. For the time being no complex elaboration on the topic have been carried out in Poland thus results of the study could make it easier to emphasize the role of proper prophylaxis on reduction of incidence of diabetic complications and costs of diabetes in Poland in perspective of public payer; it could occur basic for new diabetes policy in Poland.
MATERIAL AND METHODS. The aim of the study was to assess costs for treatment of diabetes complications as well as an elaboration of a group of complications: microangiopathy or macroangiopathy are more cost-generating for public payer in 2002. Relevant data was obtained from two sources: identification of patients with diagnosed diabetes; identification of all procedures for treatment of the patients.
RESULTS. Costs for reimbursement for treatment of diabetes complications in Poland in 2002 were assessed to be 435 million PLN in 2002.
CONCLUSIONS. Proper prophylaxis and reduction of incidence of diabetic complications would mean lower costs for treatment of diabetic complications. Pharmacoeconomic elaboration should occur a new impulse for new diabetic policy which mean elaboration and implementation for more efficient health programmes and better control for glucose level in diabetic patients in Poland.
Get Citation

Keywords

cost of illness analysis; costs for diabetes complications; reimbursement for diabetes complications in Poland; microangiopathy and macroangiopathy complications of diabetes

About this article
Title

A cost-effectiveness analysis of treatment of diabetic complications in 2002

Journal

Clinical Diabetology

Issue

Vol 5, No 1 (2004): Practical Diabetology

Pages

9-14

Published online

2004-02-02

Bibliographic record

Diabetologia Praktyczna 2004;5(1):9-14.

Keywords

cost of illness analysis
costs for diabetes complications
reimbursement for diabetes complications in Poland
microangiopathy and macroangiopathy complications of diabetes

Authors

Paweł Kawalec
Andrzej Pilc

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Diabetologia Kliniczna dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl